Complete Cytoreduction Combined with Early Postoperative Intraperitoneal Chemotherapy for Ovarian Carcinosarcoma

Publisher： Karger

E-ISSN： 1423-002x|62|2|100-102

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.62, Iss.2, 2006-08, pp. : 100-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival Impact of Adjuvant Paclitaxel and Carboplatin for Early-Stage Ovarian Clear-Cell Carcinoma with Complete Surgical Staging

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 4, 2011-10 ,pp. : 252-256

Karger

Access to resources Recommend Favorite

Can Optimal Primary Cytoreduction Be Predicted in Advanced Stage Epithelial Ovarian Cancer? Role of Preoperative Serum CA-125 Level

By  

Gynecologic and Obstetric Investigation, Vol. 57, Iss. 3, 2004-04 ,pp. : 153-156

Karger

Access to resources Recommend Favorite

Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review

By  

Gynecologic and Obstetric Investigation, Vol. 80, Iss. 4, 2015-0 ,pp. : 265-271

Karger

Access to resources Recommend Favorite

Pilot Phase 2 Trial of 4 Months of Maintenance Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer after Complete Response to Platinum and Paclitaxel-Based Chemotherapy

By  

Gynecologic and Obstetric Investigation, Vol. 63, Iss. 1, 2006-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Enormous Cystic Tumor of Peritoneal Psammocarcinoma Exhibiting Complete Response to Cisplatin and Cyclophosphamide after Suboptimal Cytoreduction: Case Report and Review of the Literature

By  

Gynecologic and Obstetric Investigation, Vol. 74, Iss. 2, 2012-05 ,pp. : 165-170

Karger

Access to resources Recommend Favorite